CoapTech Receives Seed Fund Grant from Pennsylvania Pediatric Device Consortium


The PUMA System is a new category of minimally invasive devices, enabling ultrasound procedures in hollow organs of the body where it was previously impossible or dangerous to do so. The PUMA-G Peds System is being developed to enable ultrasonic placement of gastrostomy tubes in pediatric patients as an alternative to traditional endoscopic or fluoroscopic procedures. Endoscopic procedures cannot “see through” tissue, which can lead to organ damage or other complications. Fluoroscopic procedures require the use of ionizing radiation which poses a long-term cancer risk. The PUMA-G Peds System uses ultrasound to visualize tissues and organs in real time without ionizing radiation. It is designed to function like the adult PUMA-G system currently available, with modifications to accommodate the pediatric patient population.

“CoapTech is honored to receive this competitive award from PPDC,” said the co-founder and CEO of CoapTech. Howard Carolan. “We are fortunate to be working with a strong, world-renowned clinical team as we develop this important pediatric version of the PUMA-G Feeding Tube Placement System.” The consortium chose CoapTech as one of five winners out of ten finalists competing to receive grants.

CoapTech was born from the University of Maryland, Baltimore (UMB) where the technology was developed. UMB’s technology transfer arm, UM Ventures, Baltimorealso provided direct investment in the business.

“We have seen the significant potential of CoapTech’s technology from inception and are excited to see the company advancing its PUMA System for the benefit of pediatric patients,” said Phil RobilottoAssociate Vice President of the Technology Transfer Office at University of Maryland, Baltimoreand director of UM Ventures, Baltimore.

About Coap Tech
CoapTech is a Baltimorea New York-based medical device company marketing a new platform called the PUMA System, which enables ultrasound to be used in hollow organ cavities. The PUMA (Point-of-care Ultrasound Magnet Aligned) system enables several new minimally invasive medical procedures at the bedside, dramatically reducing costs while improving patient safety and experience. The platform’s first product application, PUMA-G for Ultrasound Gastrostomy, has been cleared in the United States by the FDA via the 510(k) pathway and received CE Mark. CoapTech was selected as a 2019 Best-in-Class Medtech Innovator Startup Company and was named 2018 Maryland Incubator Company of the Year for Best Medical Device Company. Visit for more information or connect via Twitter at @coaptech.

About the Pennsylvania Pediatric Medical Device Consortium (PPDC)
Funded by the United States Food and Drug Administration and based in children’s hospital philadelphia cream (CHOP), the PPDC provides expertise and seed funding to help innovators translate promising ideas into commercial medical devices for children. The PPDC is a collaboration between CHOP, Drexel University and the University of Pennsylvania. For more information on the PPDC, visit

On children’s hospital philadelphia cream
children’s hospital philadelphia cream was founded in 1855 as the country’s first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals, and important pioneering research initiatives, Children’s Hospital has fostered many discoveries that have benefited children all over the world. Its pediatric research program is one of the largest in the country. Additionally, its unique family-centered care and public service programs have earned the 546-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit

SOURCECoapTech, Inc.


About Author

Comments are closed.